ADMA Biologics, Inc.
ADMA
$19.64
-$1.67-7.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.91% | 11.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.91% | 11.80% | |||
| Cost of Revenue | -9.91% | 20.99% | |||
| Gross Profit | 6.16% | 3.84% | |||
| SG&A Expenses | 25.60% | 11.57% | |||
| Depreciation & Amortization | -10.71% | -80.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.22% | 17.96% | |||
| Operating Income | -3.32% | 1.11% | |||
| Income Before Tax | -5.54% | 2.50% | |||
| Income Tax Expenses | -9,288.45% | -77.83% | |||
| Earnings from Continuing Operations | 211.61% | 12.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 211.61% | 12.00% | |||
| EBIT | -3.32% | 1.11% | |||
| EBITDA | -3.15% | 0.80% | |||
| EPS Basic | 209.14% | 11.02% | |||
| Normalized Basic EPS | -2.96% | 1.56% | |||
| EPS Diluted | 204.93% | 15.38% | |||
| Normalized Diluted EPS | -2.56% | 1.41% | |||
| Average Basic Shares Outstanding | 0.79% | 0.93% | |||
| Average Diluted Shares Outstanding | 0.45% | 1.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||